Baxter International Inc. logo

Baxter International Inc. (BAX)

Market Open
5 Dec, 19:07
NYSE NYSE
$
18. 62
+0.14
+0.78%
$
9.72B Market Cap
84.13 P/E Ratio
1.16% Div Yield
5,100,211 Volume
2.59 Eps
$ 18.48
Previous Close
Day Range
18.46 18.81
Year Range
17.4 37.74
Want to track BAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 69 days

Summary

BAX trading today higher at $18.62, an increase of 0.78% from yesterday's close, completing a monthly increase of 0.03% or $0. Over the past 12 months, BAX stock lost -36.67%.
BAX pays dividends to its shareholders, with the most recent payment made on Oct 01, 2025. The next announced payment will be in In 4 weeks on Jan 02, 2026 for a total of $0.01.
The last earnings report, released on Nov 14, 2025, missed the consensus estimates by -0.6%. On average, the company has fell short of earnings expectations by -0.37%, based on the last three reports. The next scheduled earnings report is due on Feb 12, 2026.
Baxter International Inc. has completed 5 stock splits, with the recent split occurring on Jul 01, 2015.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on NYSE (USD).

BAX Chart

Baxter International Inc. (BAX) Presents at Evercore 8th Annual Healthcare Conference Transcript

Baxter International Inc. (BAX) Presents at Evercore 8th Annual Healthcare Conference Transcript

Baxter International Inc. (BAX) Presents at Evercore 8th Annual Healthcare Conference Transcript

Seekingalpha | 2 days ago
Baxter Issues Recall Notice for Permanent Removal of Life2000 Ventilation

Baxter Issues Recall Notice for Permanent Removal of Life2000 Ventilation

Baxter recalls its Life2000 ventilation system over a serious cybersecurity flaw, pulling the device from the market despite no reported injuries.

Zacks | 3 days ago
Baxter International Inc. (BAX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Baxter International Inc. (BAX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Baxter International Inc. ( BAX ) Jefferies London Healthcare Conference 2025 November 18, 2025 8:00 AM EST Company Participants Kevin Moran - Vice President & Head of Investor Relations Joel Grade - Executive VP & CFO Conference Call Participants Matthew Taylor - Jefferies LLC, Research Division Presentation Matthew Taylor Jefferies LLC, Research Division Thanks for joining us for our next session. I'm Matt Taylor, the Jefferies, medical supplies and device analyst in the U.S. And I have with me management here from Baxter, including Joel Grade, the CFO; and Kevin Moran, doing Investor Relations.

Seekingalpha | 2 weeks ago

Baxter International Inc. (BAX) FAQ

What is the stock price today?

The current price is $18.62.

On which exchange is it traded?

Baxter International Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is BAX.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.16%.

What is its market cap?

As of today, the market cap is 9.72B.

What is the earnings per share?

The EPS is 0.55.

When is the next earnings date?

The next earnings report will release on Feb 12, 2026.

Has Baxter International Inc. ever had a stock split?

Baxter International Inc. had 5 splits and the recent split was on Jul 01, 2015.

Baxter International Inc. Profile

- Industry
- Sector
Andrew P. Hider CEO
NYSE Exchange
071813109 CUSIP
US Country
38,000 Employees
28 Nov 2025 Last Dividend
1 Jul 2015 Last Split
27 Oct 1981 IPO Date

Overview

Baxter International Inc. is a global healthcare company with a history dating back to 1931. With its headquarters in Deerfield, Illinois, Baxter specializes in the development and distribution of a wide range of healthcare products aimed at enhancing the health and well-being of people around the world. The company's operations are segmented into four key areas: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. These segments allow Baxter to serve a diverse range of healthcare needs, from critical care to chronic disease management. Baxter's commitment to innovation and quality is evident in its extensive product portfolio and its global presence, selling products in approximately 100 countries through a combination of direct sales force and distributors, including drug wholesalers and specialty pharmacy providers. The company's collaborative efforts, such as agreements with Celerity Pharmaceutical, LLC, and Miromatrix Medical Inc., underscore its dedication to advancing healthcare solutions.

Products and Services

  • Sterile Intravenous (IV) Solutions

    These are critical for patient hydration, medication delivery, and various forms of therapy in clinical settings.

  • Infusion Systems and Devices

    Baxter offers advanced infusion systems and devices that facilitate the safe and precise delivery of IV medications and therapies.

  • Parenteral Nutrition Therapies

    Designed for patients who cannot eat or absorb nutrients through their digestive system, these therapies provide vital nutrition intravenously.

  • Generic Injectable Pharmaceuticals

    The company supplies a range of generic injectables, including essential drugs for acute care settings.

  • Surgical Hemostat and Sealant Products

    These products are utilized to control bleeding and promote healing in surgical procedures.

  • Advanced Surgical Equipment

    Baxter provides state-of-the-art surgical equipment, including surgical video technologies and precision positioning devices, to enhance surgical efficiency and outcomes.

  • Smart Bed Systems

    These systems are designed to improve patient comfort and monitoring capabilities in healthcare settings.

  • Patient Monitoring and Diagnostic Technologies

    Baxter offers technologies for continuous monitoring and diagnosis of patients, aiding in timely and accurate healthcare delivery.

  • Respiratory Health Devices

    Devices designed to assist with breathing disorders and respiratory health management.

  • Dialysis Therapies and Services

    Providing a comprehensive suite of dialysis therapies and services, including peritoneal dialysis (PD) and hemodialysis (HD), Baxter supports patients with chronic kidney failure.

  • Adhesion Prevention Products

    These products are designed to prevent post-surgical adhesions, enhancing patient recovery and comfort.

  • Drug Compounding

    Baxter offers specialized compounding services, allowing for customized medication formulations to meet unique patient needs.

  • Inhaled Anesthesia

    Offering a range of inhaled anesthesia products, Baxter supports anesthesiologists in providing safe and effective sedation for surgical procedures.

Contact Information

Address: One Baxter Parkway
Phone: 224 948 2000